Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. May 27, 2023; 15(5): 931-939
Published online May 27, 2023. doi: 10.4240/wjgs.v15.i5.931
Table 1 Comparison of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen contents in healthy controls, colon polyps and colorectal cancer groups
Group
Healthy control
Colon polyps
Colorectal cancer
MMP22128.42 (1635.60, 3119.34)15459.62 (12244.16, 18777.56)15396.14 (6571.35, 20006.06)
MMP72612.71 (2087.86, 3110.04)3237.57 (2513.33, 3915.02)4173.63 (3023.82, 6327.17)
MMP98153.00 (5170.05, 11732.83)14288.33 (8711.57, 17994.25)10324.22 (6005.56, 14932.17)
CEA1.52 (0.79, 2.26)3.05 (1.55, 7.82)6.84 (1.86, 14.43)
Table 2 Diagnostic value of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen for distinguishing healthy control group from colorectal cancer group

AUC
Standard error
P value
95%CI
Lower
Upper
MMP20.8750.031< 0.0010.8150.935
MMP70.7860.039< 0.0010.7110.862
MMP90.7480.042< 0.0010.6670.830
CEA0.7790.038< 0.0010.7040.853
Table 3 Diagnostic value of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen for distinguishing colorectal polyp from colorectal cancer group
Indicator
AUC
Standard error
P value
95%CI
Lower
Upper
MMP20.5320.0500.5500.4330.630
MMP70.7690.042< 0.0010.6880.851
MMP90.7370.046< 0.0010.6470.827
CEA0.6260.0500.0180.5280.723